The Department of Defense (DOD) should be involved in the production of pharmaceuticals to help combat drug shortages that impact members of the military, the chair of the Senate Armed Services subcommittee on personnel suggested at a hearing, hinting that senators may pursue legislation that would allow DOD to make its own drugs. Quality issues with generic drugs , and weaknesses in FDA’s foreign inspections regime, have been pointed to as factors in drug shortages by many stakeholders. Facilities in...